Comment on ‘Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion’

por Huo, Teh-Ia, Liu, Po-Hong, Hsu, Chia-Yang
Publicado 2017

Stool-Based Tests Mitigate Impacts of COVID-19 on Colorectal Cancer Screening

por Liu, Po-Hong, Singal, Amit G., Murphy, Caitlin C.
Publicado 2023

Comparison of Hepatocellular Carcinoma in Hispanic and Non-Hispanic Patients

por Asemota, Joseph, Oladunjoye, Olubunmi, Babalola, Atinuke, Nwosu, Ugonna, Liu, Po-Hong S, Oladunjoye, Adeolu O, Castro-Webb, Nelsy, Miksad, Rebecca A
Publicado 2021

Hepatocellular Carcinoma Screening Process Failures in Patients with Cirrhosis

por Marquardt, Patrick, Liu, Po‐Hong, Immergluck, Joshua, Olivares, Jocelyn, Arroyo, Ana, Rich, Nicole E., Parikh, Neehar D., Yopp, Adam C., Singal, Amit G.
Publicado 2021

Comparison of Four Albumin-Based Liver Reserve Models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization

por Ho, Shu-Yein, Liu, Po-Hong, Hsu, Chia-Yang, Huang, Yi-Hsiang, Liao, Jia-I, Su, Chien-Wei, Hou, Ming-Chih, Huo, Teh-Ia
Publicado 2023

Hepatocellular Carcinoma Patients With Performance Status 1 Deserve New Classification and Treatment Algorithm in the BCLC System

por Hsu, Chia-Yang, Liu, Po-Hong, Lee, Yun-Hsuan, Hsia, Cheng-Yuan, Huang, Yi-Hsiang, Chiou, Yi-You, Lin, Han-Chieh, Huo, Teh-Ia
Publicado 2015

A New Tumor Burden Score and Albumin–Bilirubin Grade-Based Prognostic Model for Hepatocellular Carcinoma

por Ho, Shu-Yein, Liu, Po-Hong, Hsu, Chia-Yang, Huang, Yi-Hsiang, Liao, Jia-I, Su, Chien-Wei, Hou, Ming-Chih, Huo, Teh-Ia
Publicado 2022

Radiofrequency Ablation versus Transarterial Chemoembolization for Hepatocellular Carcinoma within Milan Criteria: Prognostic Role of Tumor Burden Score

por Ho, Shu-Yein, Liu, Po-Hong, Hsu, Chia-Yang, Huang, Yi-Hsiang, Liao, Jia-I, Su, Chien-Wei, Hou, Ming-Chih, Huo, Teh-Ia
Publicado 2022

Prognostic Prediction for Patients with Hepatocellular Carcinoma and Ascites: Role of Albumin-Bilirubin (ALBI) Grade and Easy (EZ)-ALBI Grade

por Liao, Jia-I, Ho, Shu-Yein, Liu, Po-Hong, Hsu, Chia-Yang, Huang, Yi-Hsiang, Su, Chien-Wei, Hou, Ming-Chih, Huo, Teh-Ia
Publicado 2023

Retrospective cause analysis of troponin I elevation in non-CAD patients: Special emphasis on sepsis

por Yang, Chien-Wen, Li, Huijun, Thomas, Lisa, Ramos, Manuel, Liu, Po-Hong, Roe, Thomas, Valadri, Ravinder, Kiel, Michael C., Su, Vincent Yi-Fong, Shi, Qi
Publicado 2017

Fruit and vegetable consumption is associated with lower prevalence of asymptomatic diverticulosis: a cross-sectional colonoscopy-based study

por Maxner, Benjamin, McGoldrick, Jessica, Bellavance, Danielle, Liu, Po-Hong, Xavier, Ramnik J., Yarze, Joseph C., Ricciardi, Rocco, Staller, Kyle, Chung, Daniel C., Khalili, Hamed
Publicado 2020

A New Treatment-integrated Prognostic Nomogram of the Barcelona Clinic Liver Cancer System for Hepatocellular Carcinoma

por Hsu, Chia-Yang, Liu, Po-Hong, Hsia, Cheng-Yuan, Lee, Yun-Hsuan, Nagaria, Teddy S., Lee, Rheun-Chuan, Ho, Shu-Yein, Hou, Ming-Chih, Huo, Teh-Ia
Publicado 2017

Barriers to Surveillance for Hepatocellular Carcinoma in a Multicenter Cohort

por Parikh, Neehar D., Tayob, Nabihah, Al-Jarrah, Taim, Kramer, Jennifer, Melcher, Jennifer, Smith, Donna, Marquardt, Patrick, Liu, Po-Hong, Tang, Runlong, Kanwal, Fasiha, Singal, Amit G.
Publicado 2022

Surgical resection versus transarterial chemoembolization for patients with hepatocellular carcinoma beyond Milan criteria: prognostic role of tumor burden score

por Ho, Shu-Yein, Liu, Po-Hong, Hsu, Chia-Yang, Huang, Yi-Hsiang, Lei, Hao-Jan, Liao, Jia-I, Su, Chien-Wei, Hou, Ming-Chih, Huo, Teh-Ia
Publicado 2023

Decrypting Cryptogenic Hepatocellular Carcinoma: Clinical Manifestations, Prognostic Factors and Long-Term Survival by Propensity Score Model

por Hsu, Chia-Yang, Lee, Yun-Hsuan, Liu, Po-Hong, Hsia, Cheng-Yuan, Huang, Yi-Hsiang, Lin, Han-Chieh, Chiou, Yi-You, Lee, Fa-Yauh, Huo, Teh-Ia
Publicado 2014

Using Serum α-Fetoprotein for Prognostic Prediction in Patients with Hepatocellular Carcinoma: What is the Most Optimal Cutoff?

por Hsu, Chia-Yang, Liu, Po-Hong, Lee, Yun-Hsuan, Hsia, Cheng-Yuan, Huang, Yi-Hsiang, Lin, Han-Chieh, Chiou, Yi-You, Lee, Fa-Yauh, Huo, Teh-Ia
Publicado 2015

Uncompromised Treatment Efficacy in Elderly Patients With Hepatocellular Carcinoma: A Propensity Score Analysis

por Liu, Po-Hong, Hsu, Chia-Yang, Lee, Yun-Hsuan, Hsia, Cheng-Yuan, Huang, Yi-Hsiang, Su, Chien-Wei, Chiou, Yi-You, Lin, Han-Chieh, Huo, Teh-Ia
Publicado 2014

Hong Kong Liver Cancer Staging System Is Associated With Better Performance for Hepatocellular Carcinoma: Special Emphasis on Viral Etiology

por Liu, Po-Hong, Hsu, Chia-Yang, Lee, Yun-Hsuan, Su, Chien-Wei, Hsia, Cheng-Yuan, Huang, Yi-Hsiang, Chiou, Yi-You, Lin, Han-Chieh, Huo, Teh-Ia
Publicado 2015

Solitary Large Hepatocellular Carcinoma: Staging and Treatment Strategy

por Liu, Po-Hong, Su, Chien-Wei, Hsu, Chia-Yang, Hsia, Cheng-Yuan, Lee, Yun-Hsuan, Huang, Yi-Hsiang, Lee, Rheun-Chuan, Lin, Han-Chieh, Huo, Teh-Ia
Publicado 2016

When to Perform Surgical Resection or Radiofrequency Ablation for Early Hepatocellular Carcinoma?: A Nomogram-guided Treatment Strategy

por Liu, Po-Hong, Hsu, Chia-Yang, Lee, Yun-Hsuan, Hsia, Cheng-Yuan, Huang, Yi-Hsiang, Su, Chien-Wei, Chiou, Yi-You, Lin, Han-Chieh, Huo, Teh-Ia
Publicado 2015